Phase 2 N=38 Diabetes Homeless Medication Support
Diabetes Mellitus, Type 2 · Housing Problems · Psychological Distress
Primary: Experience During the Intervention — 29.06; 28.22 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=112 Comparison of DTM™ SCS Therapy Combined With Conventional Medical Management (CMM) to CMM Alone in the Treatment of Intractable Back Pain Subjects Without Previous History of Lumbar Spine Surgery
Pain, Intractable · Pain, Chronic
Primary: Percentage of Individual Responders — 40; 2 Participants — p=<0.0001
Phase 2 N=318 A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder
Post-Traumatic Stress Disorder
Primary: Change From Baseline in Clinician-Administered Post Traumatic Stress Disorder (PTSD) Scale for DSM-5 (CAPS-5) Total Severity Score at Week 8 — -17.19; -17.13 units on a…
Phase 2 N=49 Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
Multiple Myeloma · Non-Hodgkin's Lymphoma
Primary: Number of Dose Limiting Toxicities/DLTs — 0; 1; 0; 1 DLT's
N/A N=20 Promise Women Project
Human Papilloma Virus · Cervical Cancer
Primary: Number of Women Who Undergo Cervical Cancer Screening. — 20 Participants
N/A N=326 A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)
Inflammatory Bowel Diseases · Colitis, Ulcerative · Crohn Disease
Primary: Percentage of Participants With Active CD at Day 1 — 45.3 percentage of participants
N/A N=150 Pannus Assistance Needed for Obstetric Ultrasound Studies
Obesity Complicating Childbirth · Fetal Anomaly
Primary: Completion Rate of 16 Prespecified Views — 19; 24 Participants
Phase 2 N=41 Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Primary: Safety and Tolerability — 10; 9; 10; 9 Participants with at least one TEAE
N/A N=28 Investigating the Physiological Effects of Weight Loss on Male Fertility
Male Infertility · Obesity · Weight Loss
Primary: Sperm Concentration — 53.6; 58.5; 20.1; 15 million sperms/mL
N/A N=143 Testing Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American Caregivers
Oral Health · Child · Adolescents
Primary: Knowledge Pretest Score — 64.92; 66.67 score on a scale — p=0.64
N/A N=40 Acute Effects of Cigarette Packaging and Charcoal Filtration on Perceptions, Use Behaviors, and Harm Exposure
Smoking Behaviors
Primary: Number of Puffs Taken (Video-scored Smoking Behavior Outcome 1) — 15.8; 16.7; 19.1; 19.6 puffs
N/A N=114 Novel Interventions for GWVI
Gulf War Veteran's Illness
Primary: Change in Brief Pain Inventory - Short Form (BPI) - Pain Interference — 4.47; 4.77; 3.59; 3.66 score on a scale — p=0.58
Phase 2 N=17 Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
Waldenstrom Macroglobulinemia
Primary: Percentage of Patients Achieving at Least a Major Response Rate at 24 Weeks Post Commencing Treatment — 8 Participants
N/A N=10 Healthy Kids I-PAL
Childhood Obesity
Primary: Child Acceptability of the mHealth Approach — 3.8 score on a scale
Phase 3 N=295 Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration
Neovascular Age-Related Macular Degeneration
Primary: Number of Patients With no Disease Activity at Week 16 in the Study Eye — 89 Participants